ABBOTT LABORATORIES — Director's Dealing 2009

Dec 29, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-12-23

Reporting Person: SMITHBURG WILLIAM D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-12-23	Common shares without par value	M	5678	$35.9192	Acquired	56949	Direct
2009-12-23	Common shares without par value	S	5100	$53.981	Disposed	51849	Direct
2009-12-23	Common shares without par value	S	578	$53.982	Disposed	51271	Direct
2009-12-24	Common shares without par value	M	6177	$42.7328	Acquired	57448	Direct
2009-12-24	Common shares without par value	F	4880	$54.09	Disposed	52568	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-12-23	Option (right to buy)	$35.9192	M	5678	Disposed	2010-04-27	Common shares (5678)	Direct
2009-12-24	Option (right to buy)	$42.7328	M	6177	Disposed	2011-04-26	Common shares (6177)	Direct
2009-12-24	Option (right to buy)	$54.09	A	4880	Acquired	2011-04-26	Common shares (4880)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	4309	Indirect

Footnotes

F1: Balance reflects the entire number of shares held by partnership. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F2: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

F3: Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.